Calithera is a clinical-stage, precision oncology biotechnology company developing targeted therapies to redefine treatment for biomarker-specific patient populations. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer, Calithera is advancing a pipeline of oral therapeutics to meaningfully expand treatment options available to patients. Calithera is based in South San Francisco, California.